Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report

• প্রধান লেখক: Boney Joseph (লেখক), Nicolas A. Nunez (লেখক), Simon Kung (লেখক), Jennifer L. Vande Voort (লেখক), Vanessa K. Pazdernik (লেখক), Kathryn M. Schak (লেখক), Stacey M. Boehm (লেখক), Brooke Carpenter (লেখক), Emily K. Johnson (লেখক), Grigoriy Malyshev (লেখক), Nathan Smits (লেখক), Daniel O. Adewunmi (লেখক), Sarah K. Brown (লেখক), Balwinder Singh (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2023-08-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Intravenous (IV) ketamine and FDA-approved intranasal (IN) esketamine are increasingly used for treatment-resistant depression (TRD). Preliminary studies have suggested a synergistic effect of ketamine and lamotrigine, although the data are inconclusive. Herein, we report the response to serial keta...